JILL HORNER: Open Payments
NPI 1346904927 · PANDORA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 59 payments from 15 companies in 2025. Trend: 2023 $987 · 2024 $1,603 · 2025 $1,025
Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $228 |
| Axsome Therapeutics, Inc. | 6 | $173 |
| AstraZeneca Pharmaceuticals LP | 9 | $161 |
| Lilly USA, LLC | 5 | $101 |
| Otsuka America Pharmaceutical, Inc. | 5 | $81 |
| Novo Nordisk Inc | 4 | $66 |
| Radius Health, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| BioMarin Pharmaceutical Inc. | 1 | $26 |
Products named: Auvelity, MOUNJARO, AIRSUPRA, VRAYLAR, REXULTI, LINZESS, UBRELVY, Wegovy.
Industry payments across OH — which companies pay providers there.
